JACFX
Price
$18.87
Change
-$0.73 (-3.72%)
Updated
Feb 21 closing price
Net Assets
1.31B
PEMGX
Price
$43.41
Change
-$0.75 (-1.70%)
Updated
Feb 21 closing price
Net Assets
29.57B
Ad is loading...

JACFX vs PEMGX

Header iconJACFX vs PEMGX Comparison
Open Charts JACFX vs PEMGXBanner chart's image
JHancock Mid Cap Growth NAV
Price$18.87
Change-$0.73 (-3.72%)
VolumeN/A
Net Assets1.31B
Principal MidCap A
Price$43.41
Change-$0.75 (-1.70%)
VolumeN/A
Net Assets29.57B
JACFX vs PEMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JACFX vs. PEMGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JACFX is a Hold and PEMGX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 29.6B vs. JACFX (1.31B). JACFX (0.00) and PEMGX (0.00) have matching dividends . JACFX was incepted earlier than PEMGX: JACFX (19 years) vs PEMGX (20 years). JACFX is a more actively managed with annual turnover of: 102.00 vs. PEMGX (10.10). JACFX has a lower initial minimum investment than PEMGX: JACFX (0) vs PEMGX (1000). JACFX annual gain was more profitable for investors over the last year : 21.51 vs. PEMGX (12.29). PEMGX return over 5 years is better than : 34.02 vs. JACFX (-15.87).
JACFXPEMGXJACFX / PEMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years20 years-
Gain YTD1.8901.854102%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.31B29.6B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.5112.29175%
Returns for 3 years14.8527.3054%
Returns for 5 years-15.8734.02-47%
Returns for 10 years-9.8489.11-11%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLTR2.500.05
+2.04%
Kaltura
HCKT30.18-0.51
-1.66%
Hackett Group
OKTA92.75-2.44
-2.56%
Okta
ASB24.44-0.66
-2.63%
Associated Banc-Corp
CLRB0.31-0.02
-6.88%
Cellectar Biosciences